Evolent Health, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Seth Blackley and CFO Mario Ramos certified the Q2 2026 10-Q (ended June 30, 2026) per Sarbanes-Oxley Sections 302 and 906 on August 6, 2026. The certifications affirm that disclosure controls, internal controls over financial reporting, and financial statements fairly present the company's condition. No material weaknesses, deficiencies, or control changes are disclosed in the exhibits provided.
Why this rating
Routine SOX compliance filing; standard quarterly certification exhibits. No substantive operational, financial, or control changes disclosed. Boilerplate regulatory requirement.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.